摘要
德国SCHWABE公司是银杏叶制剂的全球首家、也是最大的生产厂商。该公司不仅在该领域技术力量领先,更是通过高质量的专利撰写、严密的专利布局,有效地保护了自身产品的市场。该文通过对SCHWABE公司银杏叶制剂专利网的申请时机、法律状态、技术发展路线、全球布局、中国布局等多角度的分析,既为我国企业的银杏叶制剂研发提供了技术参考,也为中药专利网布局提供了宝贵的参考经验。
SCHWABE Company in German is the first and largest manufacturer of Ginkgo biloba preparation. The company not only has leading technology in this field, but also protects its own market effectively through the high quality of patent drafting and exactly patent layout. Based on muhi-angle analysis for patent portfolio of G. biloba preparation at application time, legal status, globally layout, Chinese layout, the article provides technical reference of research and development of G. biloba, also provides valuable experience of traditonal Chinese medicine patent portfolio layout for Chinese enterprises.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2014年第17期3384-3388,共5页
China Journal of Chinese Materia Medica
基金
教育部人文社会科学研究青年基金项目(10YJCZH095)